89bio, Inc.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Quarterly Report for period ending 2021-06-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Filing for proposed sale of securities under Rule 144

Filing for proposed sale of securities under Rule 144

Filing for proposed sale of securities under Rule 144

Filing for proposed sale of securities under Rule 144

Filing for proposed sale of securities under Rule 144

Annual report to security holders

Notice of Effectiveness

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notice of Effectiveness

Deep Track Capital, LP: Major Shareholders

Cormorant Asset Management, LP: Major Shareholders

BIOTECHNOLOGY VALUE FUND L P: Major Shareholders

RTW INVESTMENTS, LP: Major Shareholders

Mansbach Harry H: Statement of changes in beneficial ownership of securities

Martins Ryan: Statement of changes in beneficial ownership of securities

Le-Nguyen Quoc: Statement of changes in beneficial ownership of securities

PALEKAR ROHAN: Statement of changes in beneficial ownership of securities

SUVRETTA CAPITAL MANAGEMENT, LLC: Major Shareholders

JANUS HENDERSON GROUP PLC: Major Shareholders

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Automatic shelf registration statement of securities of well-known seasoned issuers

Automatic shelf registration statement of securities of well-known seasoned issuers

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(5)

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(5)

Registration statement for specified transactions by certain issuers

Registration statement for specified transactions by certain issuers

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.